CBX6 and hepatocellular carcinoma: To further investigate the clinical significance of CBX6 expression in HCC development and progression, we divided all 313 HCC patients into the following 2 groups based on their overall CBX6 expression levels: a high CBX6 expression group (n = 157) and a low CBX6 expression group (n = 156).